Review Article
Mouse Models in Prostate Cancer Translational Research: From Xenograft to PDX
Table 1
Prostatic mouse models of engraftment.
| Type | Background strain | Year | Features | Disadvantages | Reference |
| Xenograft | Nude, SCID, NOD-SCID, NOG/NSG, RAG | 1996–2006 | High take rate, low costs, LNCaP, LNCaP-LN3, PC-3, PC-3M cell lines and human prostatic tissues implanted | Immune-compromised mice tested | [23–27] |
| Allograft | C57BL/6 | 1997–1994 | High take rate, low costs, use of immune-competent mice; TRAMP-C1/2/3, PTEN-CaP8 cell lines implanted | Low translational potential | [31, 32, 38] |
| Allograft | BALBC/c | 2004 | High take rate, low costs, use of immune-competent mice; use of PNEC30 cell lines | Low translational potential Neuroendocrine originated cells | [34] |
|
|